Investor Information
Latest News
-
Virginia Tech and Indivior Announce New Collaboration to Study Long-Term Recovery in People with Opioid Use Disorder
December 10, 2019 | PDF Version
-
New Analysis From One-Year Study of Monthly Buprenorphine Extended-Release Injections Showed Improved or Stable Patient-Centered Outcomes
December 2, 2019 | PDF Version
-
Indivior Launches National Campaign Informing People of an Additional Treatment for Opioid Use Disorder (OUD) and to Let People with OUD Know That They Can “Keep Moving Towards Recovery”
November 11, 2019 | PDF Version
-
Indivior 2019 Third Quarter and Nine Months YTD Results Presentation
October 31, 2019 | PDF Version
Our Commitment
Updates on the Department of Justice Action
Get updates and information on Indivior’s ongoing response to the recent action by the U.S. Department of Justice and learn about the company’s unwavering commitment to patients, doctors, and communities fighting opioid addiction.
See more >
Upcoming Events
Webcasts/Audiocasts/Presentations
Click on the headings to view online or download a presentation:
-
November 2019 Healthcare Conferences Presentation
-
2019 Stifel Healthcare Conference (New York City)
-
Jefferies 2019 London Healthcare Conference
-
Indivior 2019 Third Quarter and Nine Months YTD Results Presentation
-
FY 2019 Year-to-Date / Q3 Results Call, October 31st at 12:00 London time (8:00 AM US Eastern)
See more
RNS Filings
View Indivior filings with the Regulatory News Service on regulatory and non-regulatory updates.
